Machine learning-based QSAR and LB-PaCS-MD guided design of SARS-CoV-2 main protease inhibitors
- 24 June 2024
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 110, 129852
Abstract
No abstract availableKeywords
Funding Information
- National Research Council of Thailand (N42A650231)
- Japan Science and Technology Agency (JPMJCR20B3)
- Ministry of Education, Culture, Sports, Science and Technology (22H04800)
- Chulalongkorn University
- Consiglio Nazionale delle Ricerche
- University of Tsukuba
This publication has 23 references indexed in Scilit:
- Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portalJournal of Computer-Aided Molecular Design, 2022
- Halogenated Baicalein as a Promising Antiviral Agent toward SARS-CoV-2 Main ProteaseJournal of Chemical Information and Modeling, 2022
- Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main ProteaseChemMedChem, 2021
- Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antiviralsBioorganic Chemistry, 2021
- Temperature‐shuffled parallel cascade selection molecular dynamics accelerates the structural transitions of proteinsJournal of Computational Chemistry, 2017
- Investigating the influence of data splitting on the predictive ability of QSAR/QSPR modelsStructural Chemistry, 2011
- Biological activities of natural halogen compounds2001
- Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditionsBiochemical Pharmacology, 1987
- A novel biologically active seleno-organic compound—IIBiochemical Pharmacology, 1984
- A novel biologically active seleno-organic compound—1Biochemical Pharmacology, 1984